Systematic Discovery in Microbiome and Biomarker Research for Enhanced Immunotherapy

The field of systems biology sits at the frontier of unraveling complex biological interactions, particularly in the context of therapy responses. Immunotherapies have notably transformed treatment approaches for a variety of diseases, including cancer and chronic inflammatory conditions. Despite their transformative potential, the ability to predict individual patient responses and optimize therapeutic outcomes remains a significant clinical challenge. Recent advancements have highlighted the pivotal role of systematic biomarker discovery and microbiome research as essential components in understanding these challenges, especially concerning immunotherapy responses.The Research Topic aims to integrate these two burgeoning fields, emphasizing the potential to leverage biomarker and microbiome data to better determine and predict responses to immunotherapy. As our understanding of the biological intricacies involved with immunological responses expands, this intersection offers novel avenues for targeted research. Achieving a more personalized and effective approach to therapy will rely heavily on these insights. This Research Topic seeks to explore key questions, such as the ways in which microbial populations influence immune functions, and how these factors may be utilized to enhance biomarker-driven patient stratifications for immune-based therapies.To gather further insights in this exciting intersection, we welcome articles addressing, but not limited to, the following themes:• Systematic identification and validation of biomarkers that can pinpoint early detection and stratify immunotherapy-responsive patients.• Mechanistic explorations of how the microbiome affects immune system dynamics and consequently immunotherapy outcomes.• The use of integrative multi-omic and computational modeling to correlate genomic, transcriptomic, proteomic, and microbiome data with therapeutic success.• Investigate systems-level dynamics in immunology, detailing network interactions and signaling pathways affecting individual variances in treatment responses.• The development of digital twin and predictive models considering both biomarker and microbiome contributions for personalized immune response simulations.• Advancements in bioinformatics tools and algorithms designed to effectively analyze complex datasets spanning host immunity, biomarker discovery, and microbiota research.• Translation of systems-level findings into clinical applications, enhancing trial design, patient monitoring practices, and precision medicine strategies in immunotherapy.We encourage contributions that will advance knowledge at this crucial intersection, fostering interdisciplinary study and laying the groundwork for more targeted and efficient immunotherapeutic strategies. Topic editors: Prosper Obed Chukwuemeka, Gratiela Gradisteanu Pircalabioru, Akhil Kapoor, Arun Kumar Mishra Source: https://www.frontiersin.org/research-topics/79499/systematic-discovery-in-microbiome-and-biomarker-research-for-enhanced-immunotherapy